« Back
Home /
Trastuzumab

Trastuzumab

Manufacturer	TargetMol
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	5mg
Item no.	TMO-T9912-5mg
Targets	EGFR
CASRN	180288-69-1
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Shipping	cool pack
Storage	-20°
Molecular Weight	146 kDa
Pathway	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|JAK/STAT signaling
Target	EGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 5/9/2024